News
Robinson taught at the Writer’s Workshop at the University of Iowa and earned a Pulitzer Prize for “Gilead” back in 2005.
Gilead Sciences’ sponsorship of a conference Wi-Fi network has landed it in hot water. U.K drug marketing watchdog the PMCPA ruled the network login process, which directed users to Gilead’s U ...
In this article, we are going to take a look at where Gilead Sciences Inc. (NASDAQ:GILD) stands against other undervalued quality stocks to buy now. On February 24, Kayne Anderson Rudnick chief ...
On The Handmaid's Tale Season 6 Episode 4 Joseph gets a promotion for his reforms while the resistance plans a major assault ...
Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...
Gilead Sciences, Inc. (GILD), based in Foster City, California, is a leading biopharmaceutical company focused on developing and commercializing groundbreaking therapies for diseases like HIV ...
Less than three years after being spun out of Oxford University, privately-held biotech MiroBio is heading for a takeover by Gilead Sciences in a $405 million deal.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Credit - Photo-illustration by TIME; Cihlar: Gilead Sciences, Inc.; Sundquist: University of Utah Today, antiviral medications can turn HIV, a once fatal infection, into a chronic condition.
Discover a fantastic opportunity to secure a 512sqm registered block in the vibrant Figtree Hill Estate, Gilead. Perfect for families and investors, this flat and ready-to-build land is located in ...
Novartis has terminated a phase 2 trial evaluating an investigational ADAMTS-5 inhibitor for patients with osteoarthritis knee pain. The Big Pharma company discontinued the study testing intra ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results